These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1484986)

  • 41. [The treatment of prostatic cancer: present and future, realities and possibilities].
    Vera Donoso CD
    Actas Urol Esp; 2007 Jun; 31(6):575-9. PubMed ID: 17896552
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The importance of early diagnosis of carcinoma of the prostate].
    Servadio C; Nissenkorn I
    Harefuah; 1976 Nov; 91(9):265-8. PubMed ID: 1010473
    [No Abstract]   [Full Text] [Related]  

  • 43. [Prostatic cancer: overtreatment and overdiagnosis].
    García González R; Mayayo Dehesa T
    Arch Esp Urol; 2006; 59(6):563-9. PubMed ID: 16933484
    [No Abstract]   [Full Text] [Related]  

  • 44. Reporting intraductal carcinoma of the prostate: a plea for greater standardization.
    Varma M; Egevad L; Delahunt B; Kristiansen G
    Histopathology; 2017 Feb; 70(3):504-507. PubMed ID: 27614104
    [No Abstract]   [Full Text] [Related]  

  • 45. POINT: EPCA-2: a promising new serum biomarker for prostatic carcinoma?
    Diamandis EP
    Clin Biochem; 2007 Dec; 40(18):1437-9. PubMed ID: 17945209
    [No Abstract]   [Full Text] [Related]  

  • 46. Prostate cancer--in search of certain knowledge.
    Rukstalis DB
    J Urol; 1996 Oct; 156(4):1386-7. PubMed ID: 8808877
    [No Abstract]   [Full Text] [Related]  

  • 47. Problem of prostate cancer.
    Scardino PT
    J Urol; 1994 Nov; 152(5 Pt 2):1677-8. PubMed ID: 7933223
    [No Abstract]   [Full Text] [Related]  

  • 48. Carcinoma of the prostate.
    McRoberts JW; Mulcahy JJ
    J Ky Med Assoc; 1978 Mar; 76(3):127-9. PubMed ID: 564928
    [No Abstract]   [Full Text] [Related]  

  • 49. Carcinoma of the prostate.
    Gittes RF
    N Engl J Med; 1991 Jan; 324(4):236-45. PubMed ID: 1985245
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical management of stage A1 adenocarcinoma of prostate gland.
    Harrison RH
    Urology; 1983 Apr; 21(4):437. PubMed ID: 6836844
    [No Abstract]   [Full Text] [Related]  

  • 51. [Metastases in carcinoma of the prostate].
    VILLANUEVA A
    Gac Med Mex; 1954; 84(3):187-95. PubMed ID: 13191509
    [No Abstract]   [Full Text] [Related]  

  • 52. [Stilbene indications and dosage in the therapy of prostatic carcinoma].
    SCHULTHEIS T; KAUFHOLD N
    Munch Med Wochenschr; 1951 Jun; 93(22):1123-8. PubMed ID: 14852903
    [No Abstract]   [Full Text] [Related]  

  • 53. New horizons in the surgical management of carcinoma of the prostate gland.
    GUTIERREZ R
    Am J Surg; 1949 Aug; 78(2):147-69. PubMed ID: 18135629
    [No Abstract]   [Full Text] [Related]  

  • 54. [RELATION OF THE MORPHOLOGICAL PICTURE TO THE CLINICAL COURSE OF PROSTATIC CANCER].
    WOJEWSKI A
    Pol Przegl Chir; 1963 Nov; 35():SUPPL:1293-301. PubMed ID: 14125509
    [No Abstract]   [Full Text] [Related]  

  • 55. [Pathology of the prostate carcinoma].
    BIBUS B
    Krebsarzt; 1953 Jun; 8(5-6):144-9. PubMed ID: 13097966
    [No Abstract]   [Full Text] [Related]  

  • 56. [The importance of tumor markers in adenocarcinoma of the prostate].
    Sampalmieri G; Giancola FL; Cabras A
    Riv Eur Sci Med Farmacol; 1992; 14(2):139-42. PubMed ID: 1484986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
    Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH
    Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer].
    Akimoto S; Akakura K; Masai M; Isaka S; Shimazaki J
    Hinyokika Kiyo; 1990 Jul; 36(7):783-91. PubMed ID: 1700588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
    Akdaş A; Simşek F; Ilker Y; Türkeri L; Ercan H
    Int Urol Nephrol; 1993; 25(3):271-8. PubMed ID: 7693607
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Stamey TA; Ekman PE; Blankenstein MA; Cooper EH; Kontturi M; Lilja H; Oesterling JE; Stenman UH; Turkes A
    Scand J Urol Nephrol Suppl; 1994; 162():73-87; discussion 115-27. PubMed ID: 7529430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.